Local Therapy for Oligometastatic Esophageal Squamous Cell Cancer Patients Treated With PD-1 Inhibitor: a Prospective, Randomized, Phase III Clinical Trial.

Conditions: Esophageal Squamous Cell Carcinoma; Oligometastatic Disease; Radiotherapy Interventions: Combination Product: PD-1 inhibitor+/- chemotherapy combined with local therapy; Drug: PD-1 inhibitor+/- chemotherapy alone Sponsors: Fudan University Recruiting

https://clinicaltrials.gov/study/NCT06190782

Source: ClinicalTrials.gov - January 4, 2024 Category: Research Source Type: clinical trials